← Leaderboards
Susan C Bock
Temple University
$2,699,109
Attributed
$2,699,109
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $582.7K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$2,699,109 · 4
By mechanism
R01$1,421,475 · 1
R21$822,246 · 2
P01$455,388 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Heparin”
- Thomas L Ortel · Duke University$23,256,763
- Mortimer Poncz · University Of Pennsylvania$22,311,527
- Umesh Ramanlal Desai · Versiti Blood Health, Inc.$11,929,621
- Douglas Brock Cines · Duke University$11,304,101
- Patricio Ernesto Ray · Children'S National Medical Center$11,000,597
- Erik Ian Tucker · Aronora, Inc.$10,952,616
Research focus
HeparinProtease InhibitorAntithrombin IiiFutureAmino AcidsHemagglutininFrequencies (Time Pattern)AntibodiesEpidemicEscape MutantAvian Influenza A VirusBaseAntigensH5 HemagglutininDatabasesDesignBird Flu VaccineBirdsAntibody FormationDomestic FowlsAvian InfluenzaEpitopesDisease OutbreaksFright
Grant awards (12)
Development of Cross Protective H5 Hemagglutinin Antigens$186,244
R21 · FY2010 · AI · contact PI
Development of Cross Protective H5 Hemagglutinin Antigens$11,438
R21 · FY2010 · AI · contact PI
Development of Cross Protective H5 Hemagglutinin Antigens$225,750
R21 · FY2009 · AI · contact PI
Conformational change propagation in ATIII-heparin$318,945
R01 · FY2008 · HL · contact PI
Conformational change propagation in ATIII-heparin$362,494
R01 · FY2007 · HL · contact PI
Conformational change propagation in ATIII-heparin$328,471
R01 · FY2006 · HL · contact PI
Antithrombin targeting to HSPG & heparin coated surfaces$182,484
R21 · FY2006 · HL · contact PI
Conformational change propagation in ATIII-heparin$45,190
R01 · FY2006 · HL · contact PI
Conformational change propagation in ATIII-heparin$366,375
R01 · FY2005 · HL
Antithrombin targeting to HSPG &heparin coated surfaces$216,330
R21 · FY2005 · HL
SERPIN STRUCTURE AND THE DEVELOPMENT OF NEUTROPHIL RESISTANT SERPINS$290,033
P01 · FY2001 · HL
SERPIN STRUCTURE AND THE DEVELOPMENT OF NEUTROPHIL RESISTANT SERPINS$165,355
P01 · FY2000 · HL